4D Molecular Therapeutics Inc
NASDAQ:FDMT

Watchlist Manager
4D Molecular Therapeutics Inc Logo
4D Molecular Therapeutics Inc
NASDAQ:FDMT
Watchlist
Price: 7.97 USD -1.6% Market Closed
Market Cap: 455.4m USD

Wall Street
Price Targets

FDMT Price Targets Summary
4D Molecular Therapeutics Inc

Wall Street analysts forecast FDMT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FDMT is 33.77 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.

Lowest
Price Target
17.17 USD
115% Upside
Average
Price Target
33.77 USD
324% Upside
Highest
Price Target
47.25 USD
493% Upside
4D Molecular Therapeutics Inc Competitors:
Price Targets
CYTK
Cytokinetics Inc
32% Upside
CRVO
Diffusion Pharmaceuticals Inc
183% Upside
ELDN
Eledon Pharmaceuticals Inc
410% Upside
ZNTL
Zentalis Pharmaceuticals Inc
298% Upside
HALO
Halozyme Therapeutics Inc
13% Upside
CMPX
Compass Therapeutics Inc.
143% Upside
LCTX
Lineage Cell Therapeutics Inc
159% Upside
ATX
Amplia Therapeutics Ltd
243% Upside

Revenue
Forecast

Revenue Estimate
4D Molecular Therapeutics Inc

For the last 6 years the compound annual growth rate for 4D Molecular Therapeutics Inc's revenue is -63%. The projected CAGR for the next 4 years is 456%.

-63%
Past Growth
456%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Operating Income
Forecast

Operating Income Estimate
4D Molecular Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
4D Molecular Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FDMT's stock price target?
Price Target
33.77 USD

According to Wall Street analysts, the average 1-year price target for FDMT is 33.77 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.

What is 4D Molecular Therapeutics Inc's Revenue forecast?
Projected CAGR
456%

For the last 6 years the compound annual growth rate for 4D Molecular Therapeutics Inc's revenue is -63%. The projected CAGR for the next 4 years is 456%.

Back to Top